MedTrace Logo

The Intrathecal Morphine for Nephrectomy

NCT01997788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2015-07-03

No results posted yet for this study

Summary

To evaluate the efficacy and the safety of the intrathecal morphine injection in the open nephrectomy.

Conditions

Interventions

DRUG

The intrathecal morphine injection

A single injection of morphine intrathecally

DRUG

The intravenous patient-controlled analgesia

The intravenous injection of morphine using the patient-controlled analgesia machine

DRUG

Demerol on demand

Demerol 25 mg intravenously when pain scores more than 5.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Deok-Man Hong, PhD · Seoul National University of Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01997788 on ClinicalTrials.gov